Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Schizophr Res. 2015 Apr 11;165(1):76–82. doi: 10.1016/j.schres.2015.03.033

Table 2.

Scores on Everyday Outcomes and Predictor Variables In Four Samples of People with Schizophrenia

Mt. Sinai Sample VALERO I VALERO II SCOPE
n=233 n=195 n=214 n=179
Variable
M SD M SD M SD M SD F p
Everyday Functioning
SLOF Interpersonal Functions 29.78 5.37 24.84 6.31 22.45 5.97 23.03 6.23 72.02 .001
SLOF Activities Subscale 49.06 8.54 48.35 8.61 44.40 10.66 47.52 8.55 34.34 .001
SLOF Vocational Subscale 24.23 5.64 23.92 4.67 20.06 5.29 24.92 4.34 30.53 .001
Predictor Variables
Cognition Composite Score 36.02 9.83 37.90 9.94 37.41 8.71 37.36 8.08 5.27 .005
UPSA-B Score 69.03 19.64 70.66 13.14 70.57 14.98 70.08 13.97 15.54 .001
Negative Symptoms 13.16 5.65 15.35 6.09 15.61 6.64 14.36 5.32 28.86 .001
BDI-II 11.90 10.07 15.80 12.02 15.33 11.68 16.83 12.18 56.24 .001

Note. Mt. Sinai Patients are from New York; Valero I patients are from Atlanta and San Diego; Valero II patients are from Atlanta, San Diego, and Miami; SCOPE patients are from Miami and Dallas.